Fortrade Canada Ltd. as an order-execution only dealer is not permitted to provide you with any advice or recommendations. These Market Commentaries should not be construed as a recommendation, advice or any attempt by Fortrade Canada Ltd. to prompt or influence you in making an investment decision to purchase, sell, hold or exchange any security or to influence the timing of such activity. This content is produced by Fortrade Limited which is not registered in any capacity with any securities regulatory authority in Canada.
71% of retail investor accounts lose money when trading CFDs with this provider.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
70.91% of retail investor accounts lose money when trading CFDs with this provider.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70.91% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing all your money. Read full risk warning.
US Session Analysis for CFD Instruments 04/10/2021
Fundamental analysis
04 October, 2021
U.S. stock futures edged down, as bond yields ticked up and investors weighed continued uncertainty about the debt ceiling and indebted property developer China Evergrande Group.
Futures tied to the S&P 500 slipped 0.3%, pointing to a shaky start to the week for the broad-market index after it closed last week down 2.2%. Nasdaq-100 futures declined 0.5% Monday, suggesting an extension to the recent volatility in technology stocks. Tesla shares rose 1.7% in premarket trading after the auto maker reported record deliveries in the third quarter. Merck climbed more than 3%, suggesting an extension of Friday’s gains into a second trading session, after the pharmaceutical company said its antiviral pill was effective against Covid-19 in a late-stage trial. Investors are watching negotiations in Congress closely, as lawmakers debate the debt ceiling ahead of a deadline this month to raise it so the government can pay its bills. Meanwhile, Democrats are considering scaling back the next spending package to improve its chances of being passed. The Biden administration is also set to unveil its China trade policy following a review of import tariffs.
